---
id: H-CHEM-131-145
title: Pharmaceutical Chemistry Deep Hypotheses
grade: mixed (4 GREEN, 0 ORANGE, 8 WHITE, 3 BLACK)
domain: pharmaceutical chemistry
verified: 2026-03-28
summary: "4 exact, 8 trivial/coincidence, 3 wrong"
dependency: Golden Zone dependent (unverified model)
---

# Pharmaceutical Chemistry Hypotheses (H-CHEM-131 to 145)
**n6 Grade: 🟩 EXACT** (auto-graded, 12 unique n=6 constants)


> **Hypothesis**: Drug design rules, molecular properties, and pharmacokinetic
> parameters exhibit structural connections to the perfect number n=6 and its
> number-theoretic functions (sigma, tau, phi, sigma_{-1}).

## Background

Pharmaceutical chemistry operates at the intersection of organic chemistry,
biology, and medicine. If n=6 has structural significance beyond pure mathematics,
drug design -- which depends on molecular geometry, metabolism, and biological
timing -- might reflect that structure. These 15 hypotheses test specific
quantitative claims across three pharmaceutical domains.

## Verification Summary

```
  Total: 15 hypotheses
  GREEN  (exact/proven):         4  (H-CHEM-132, 134, 140, 145)
  ORANGE (structural match):     0
  WHITE  (trivial/coincidence):  8  (H-CHEM-131, 135, 136, 137, 138, 141, 143, 144)
  BLACK  (wrong/no connection):  3  (H-CHEM-133, 139, 142)

  Texas Sharpshooter (null p=0.20): Z=0.64, p=0.36
  Script: verify/verify_chem_pharma_deep.py
  Run:    PYTHONPATH=. python3 verify/verify_chem_pharma_deep.py
```

## Grade Distribution (ASCII)

```
  GREEN  |####                | 4/15  (27%)
  ORANGE |                    | 0/15  ( 0%)
  WHITE  |########            | 8/15  (53%)
  BLACK  |###                 | 3/15  (20%)
         +----+----+----+----+
         0    4    8   12   15
```


## A. Drug Design Rules (H-CHEM-131 to 135)

### H-CHEM-131: Drug-Likeness Parameter Count = 6

> Lipinski's Rule of 5 gives 4 parameters (MW, logP, HBD, HBA).
> Veber's extension adds 2 (rotatable bonds, PSA). Total = 6 = n.

| Filter Set | Parameters | Count |
|---|---|---|
| Lipinski (Ro5) | MW<500, logP<5, HBD<=5, HBA<=10 | 4 |
| Veber extension | RotBonds<=10, PSA<=140 | 2 |
| **Combined** | | **6** |

**Grade: WHITE** -- Arithmetically exact (4+2=6) but cherry-picked. Lipinski alone = 4.
Extended filters (Ghose, Lead-likeness, GSK 4/400) give different counts. The "6"
depends entirely on choosing exactly the Lipinski+Veber combination.

---

### H-CHEM-132: Benzene Ring Prevalence in FDA Drugs > 2/3

> Over 2/3 of FDA-approved small-molecule drugs contain a 6-membered ring.

| Metric | Value | Source |
|---|---|---|
| Drugs with any aromatic ring | ~85% | Ritchie & Macdonald 2009 |
| Drugs with 6-membered ring | ~68% | Taylor et al., J Med Chem 2014 |
| Threshold (2/3) | 66.7% | -- |

```
  FDA drugs with 6-membered ring
  |===================>    | 68%
  |                        |
  0%     25%     50%  2/3  100%
                       ^
                   threshold
```

**Grade: GREEN** -- 68% > 66.7%. Well-established pharmaceutical fact. Benzene (C6H6) is
the dominant scaffold in medicinal chemistry. The n=6 connection is real in the sense
that carbon's hexagonal chemistry dominates drug space, but the TECS mapping is post-hoc.

---

### H-CHEM-133: Drug Metabolism Types = 6

> Phase I (3 types: oxidation, reduction, hydrolysis) + Phase II (3 types) = 6.

| Phase | Reaction Types | Count |
|---|---|---|
| Phase I | Oxidation, Reduction, Hydrolysis | 3 |
| Phase II | Glucuronidation, Sulfation, Glutathione conjugation, Acetylation, Methylation, Amino acid conjugation | **6** |
| **Total** | | **9** |

**Grade: BLACK** -- The original claim (3+3=6) is factually wrong. Phase II has 6 major
types, not 3. Total = 3+6 = 9. Interestingly, Phase II alone = 6 = n, but the
hypothesis as stated (Phase I + Phase II = 6) is refuted.

---

### H-CHEM-134: Major CYP450 Isoforms = 6

> The 6 major drug-metabolizing CYP450 enzymes handle >90% of Phase I metabolism.

| Isoform | Approx % Drugs Metabolized |
|---|---|
| CYP3A4 | ~50% |
| CYP2D6 | ~25% |
| CYP2C9 | ~10% |
| CYP2C19 | ~5% |
| CYP1A2 | ~5% |
| CYP2E1 | ~3% |
| **Total** | **~98%** |

**Grade: GREEN** -- The standard textbook enumeration lists exactly 6 major CYP isoforms
(Goodman & Gilman's Pharmacological Basis of Therapeutics). Caveat: some sources add
CYP2B6 (making 7) or omit CYP2E1 (making 5), but the canonical "big 6" is well-established.

---

### H-CHEM-135: Therapeutic Index Geometric Mean ~ sigma(6)

> The geometric mean of therapeutic indices across common drugs ~ 12 = sigma(6).

| Category | Drugs (TI) |
|---|---|
| Narrow TI | warfarin(2.5), digoxin(2.5), lithium(3), phenytoin(2), theophylline(3), carbamazepine(3) |
| Moderate | acetaminophen(10), metformin(10), aspirin(15), fluoxetine(10), metoprolol(12), lisinopril(20) |
| Wide TI | ibuprofen(100), amoxicillin(40), cetirizine(50), omeprazole(30), atorvastatin(80) |

```
  TI distribution (log scale)
  1     3    10   30   100
  |-----|-----|-----|-----|
  narrow moderate   wide
        ^geo.mean=11.1
        sigma(6)=12
```

**Grade: WHITE** -- Geometric mean = 11.1, within 7.6% of sigma(6)=12. But TI varies by
orders of magnitude. The sample is small and chosen to span the range. A different
drug selection would shift the geometric mean easily.


## B. Molecular Properties (H-CHEM-136 to 140)

### H-CHEM-136: Aspirin MW = sigma(6) x 15.01

> Aspirin (C9H8O4) MW = 180.16 = 12 x 15.01.

| Quantity | Value |
|---|---|
| Aspirin MW | 180.16 g/mol |
| sigma(6) x 15.01 | 180.12 |
| Error | 0.022% |

**Grade: WHITE** -- Arithmetically near-exact but completely ad hoc. 15.01 has no
chemical meaning in aspirin's context (it approximates N+H mass, but aspirin has
no nitrogen). Any MW divisible by 12 can be expressed this way.

---

### H-CHEM-137: Caffeine Atom Count = sigma(6) x sigma_{-1}(6)

> Caffeine (C8H10N4O2) has 24 atoms = 12 x 2 = sigma(6) x sigma_{-1}(6).

| Component | Atoms |
|---|---|
| C | 8 |
| H | 10 |
| N | 4 |
| O | 2 |
| **Total** | **24** |
| sigma(6) x sigma_{-1}(6) | 12 x 2 = **24** |

**Grade: WHITE** -- Exact match, but 24 = 4! admits many factorizations. Atom counts of
20-30 are common for small drug molecules. This is coincidence.

---

### H-CHEM-138: Average Aromatic 6-Rings per Drug ~ sigma_{-1}(6)

> Top-200 drugs average ~2.3 aromatic 6-membered rings per molecule ~ sigma_{-1}(6) = 2.

**Grade: WHITE** -- 2.3 is within 15% of 2, but 2 is a trivially common number. The match
is not structurally meaningful.

---

### H-CHEM-139: Drug Receptor Hill Coefficient / Ka

> Drug-receptor binding Ka and Hill coefficient n_H show n=6 connection.

**Grade: BLACK** -- Most drugs have n_H = 1 (simple Langmuir binding). Ka values span
many orders of magnitude. No non-trivial connection to n=6 found. sigma_{-1}(6)/2 = 1
is a forced mapping.

---

### H-CHEM-140: Histidine Imidazole pKa = 6 = n

> Histidine's imidazole side chain has pKa = 6.0, exactly equal to n.

| Functional Group | pKa Range |
|---|---|
| Carboxylic acid | 2-5 |
| **Imidazole** | **6-7** |
| Phenol | 8-10 |
| Protonated amine | 8-11 |
| Thiol | 8-11 |
| Amide | 15-17 |

```
  pKa scale
  0   2   4   6   8  10  12  14  16
  |---|---|---|---|---|---|---|---|
          COOH His  SH  NH3+
               ^
           pKa = 6.0 = n
```

**Grade: GREEN** -- Histidine pKa = 6.0 is an exact physical fact. Histidine is the only
amino acid with pKa near physiological pH, making it uniquely important for enzyme
catalysis and pH-sensitive drug-target interactions. The n=6 mapping is post-hoc,
but the biological significance of pKa=6 is real.


## C. Pharmacokinetics (H-CHEM-141 to 145)

### H-CHEM-141: Modal Drug Half-Life Range = n to sigma(n) Hours

> The most common oral drug half-life range is 6-12 hours.

| Half-Life Range | Fraction of Drugs |
|---|---|
| Ultrashort (<1h) | ~5% |
| Short (1-4h) | ~20% |
| **Medium (4-12h)** | **~40%** |
| Long (12-24h) | ~25% |
| Very long (>24h) | ~10% |

**Grade: WHITE** -- The modal bin is 4-12h (not 6-12h). The "6" was cherry-picked as
a sub-boundary. Median is ~7h, not 6h exactly.

---

### H-CHEM-142: Volume of Distribution ~ 1/e

> Typical drug Vd falls near GZ center (1/e = 0.368 L/kg).

**Grade: BLACK** -- Vd varies from 0.04 to 20+ L/kg across drug classes. No single
"typical" value exists. The connection is meaningless.

---

### H-CHEM-143: Hepatic Extraction Boundary ~ 1/e

> The low/intermediate extraction ratio boundary (E=0.3) approximates 1/e = 0.368.

**Grade: WHITE** -- E=0.3 is a round-number convention, 18.5% from 1/e. The exp(-1) term
does appear in first-order elimination kinetics, but that is inherent to ANY exponential
process, not specific to n=6.

---

### H-CHEM-144: Bioavailability at E=1/e Uses P!=NP Gap Ratio

> At hepatic extraction E=1/e, the surviving fraction = 1-1/e = 0.632 (TECS gap ratio).

| Parameter | Value |
|---|---|
| f_abs (absorption) | 0.9 |
| f_gut (gut survival) | 0.9 |
| E = 1/e | 0.3679 |
| F = f_abs x f_gut x (1-E) | **0.512** |
| 1-1/e | 0.6321 |

**Grade: WHITE** -- 1-1/e appears because elimination IS exponential decay. This is a
tautological property of first-order kinetics, present in every exponential system.
Not a TECS-specific connection.

---

### H-CHEM-145: Dosing Intervals = Divisors of 24 = Divisors of sigma(6) x sigma_{-1}(6)

> Standard dosing intervals {4, 6, 8, 12, 24} hours equal the divisors of 24 that are >= 4.

| Divisor d of 24 | 24/d = interval (h) | Standard? |
|---|---|---|
| 1 | 24 | Yes (QD) |
| 2 | 12 | Yes (BID) |
| 3 | 8 | Yes (TID) |
| 4 | 6 | Yes (QID) |
| 6 | 4 | Yes (Q4H) |
| 8 | 3 | No (not standard) |
| 12 | 2 | No |
| 24 | 1 | No |

```
  Standard dosing intervals (hours)
  4    6    8         12              24
  |----|----|---------|---------------|
  Q4H  QID  TID      BID             QD
  = divisors of 24 >= 4

  24 = sigma(6) x sigma_{-1}(6) = 12 x 2
```

**Grade: GREEN** -- The five standard dosing intervals are exactly the divisors of 24
that are >= 4 hours. And 24 = sigma(6) x sigma_{-1}(6). The arithmetic is exact.
Caveat: 24 hours/day is an Earth-rotation artifact, not a physical law. Dosing
intervals are driven by pharmacokinetics AND clinical convenience.


## Interpretation

The 4 GREEN results fall into two categories:

1. **Chemistry facts where 6 appears genuinely** (H-CHEM-132: benzene dominance,
   H-CHEM-134: CYP450 count, H-CHEM-140: histidine pKa)
2. **Arithmetic of 24 = sigma(6) x 2** (H-CHEM-145: dosing intervals)

The first category reflects carbon chemistry's hexagonal preference, which is real
but predates TECS theory. The second reflects the divisibility properties of 24,
which is highly composite and appears frequently in human timekeeping.

The Texas Sharpshooter test (Z=0.64, p=0.36) indicates these results are consistent
with chance at the 20% per-hypothesis base rate. No anomalous clustering detected.

## Limitations

- Literature values for drug statistics (TI, Vd, half-life distributions) vary by source
- CYP450 "major 6" is the most common but not universal enumeration
- All n=6 mappings to pharmaceutical parameters are post-hoc
- 1/e connections in pharmacokinetics are properties of exponential decay, not TECS-specific
- Molecular weight and atom count matches are pure numerology

## Verification Direction

- Cross-validate CYP450 count across multiple pharmacology textbooks
- Quantify benzene ring prevalence more precisely using ChEMBL/DrugBank databases
- Test whether Phase II conjugation types = 6 is robust across classification schemes
- Compare dosing interval structure across non-24h clinical settings (e.g., ICU continuous infusion)
